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with the single-dose gentamicin and amoxicillin regimen in terms of microbiological outcome.
Materials and Methods
In our hospital, guidelines for antibiotic prophylaxis for trauma cases have changed since December 2007, based on the local experience of cefuroxime-resistant pathogens and concern over Clostridium difficile infections. 6 The previous regimen was intravenous cefuroxime 1.5 g on induction of anaesthesia, followed by 2 doses of cefuroxime 750 mg at postoperative 8 and 16 hours. Further intra-operative doses were occasionally given at the operating surgeon's discretion, especially when surgeries were prolonged. The new regimen consisted of a single dose of intravenous amoxicillin 2 g (child, 25 mg/kg) and gentamicin 5 mg/kg at induction only. For patients allergic to penicillin, intravenous teicoplanin 400 mg (child, 10 mg/kg) plus gentamicin 5 mg/kg was administered at induction only.
Records of 2 matched groups of patients who underwent hip hemiarthroplasty for femoral neck fractures were reviewed. 29 men and 84 women (mean age, 82 years) who received the 3-dose cefuroxime regimen in 2006 were compared with 23 men and 84 women (mean age, 83 years) who received the singledose gentamicin and amoxicillin regimen in 2008.
Patient demographics, antibiotics prescribed in the peri-and immediate postoperative period, microbiological evidence of C difficile 'infection' (faecal culture and/or toxin positivity), length of hospital stay, mortality, as well as biochemical and haematological findings were reviewed. Chi-squared tests and Wilcoxon tests were used for comparison of non-parametric data. Student's t test was used for parametric data. A p value of <0.05 was considered statistically significant.
results
The 3-dose cefuroxime group was significantly higher in terms of the mean length of hospital stay (17 vs. 13 days, p=0.043, Wilcoxon rank-sum test) and the percentage of patients receiving postoperative antibiotics (88% vs. 68%, p<0.001) and having C difficile 'infection' (6% vs. 0%, p=0.016) [ Table 1 ]. The use of ciprofloxacin could be a potential cause of C difficile infection, but none of the 7 patients with C difficile 'infection' received ciprofloxacin. If patients with C difficile 'infection' were excluded, there was no significant difference in the length of hospital stay. Although the 180-day mortality was higher in the 3-dose cefuroxime group (29% vs. 15%, Table 2 ), the causes of the deaths were not collected and may not be associated with the change in antibiotic regimen.
Wounds were routinely swabbed by nursing staff if infection was suspected. Therefore, more swabs were taken than clinically necessary. In the 3-dose cefuroxime group, the mean preand post-operative levels of serum creatinine was significantly different (99±41 vs. 93±39, p=0.001) but not with respect to serum urea levels. In the gentamicin and amoxicillin group, the mean preand post-operative levels of serum urea levels was significantly different (8±4 vs. 9±5, p=0.002) but not with respect to serum creatinine levels. Nonetheless, all of these values were within the normal reference ranges matched for the patient age. Respectively for males and females aged >67 years, the normal ranges for serum creatinine levels were 78 to 130 and 60 to 110 μmol/L, 7 and for serum urea levels were 3.7 to 12.1 and 3.2 to 10.0 mmol/L. 8 The pre-and postoperative white cell counts and haemoglobin levels were also not significantly different.
discussion
Cephalosporins are active against Gram-negative bacteria, but their use is associated with a high risk of C difficile infection. 9 Gentamicin is an aminoglycoside, which has activity against most of Gram-negative bacteria. Amoxicillin belongs to the beta-lactam group of antibiotics, and has a broad-spectrum activity against several Gram-positive and -negative microorganisms. Culture positive without toxin positivity is generally regarded as colonisation and not clinically significant infection.
Two recent meta-analyses show no significant difference in infection rates between single-and multiple-dose regimens of antibiotic prophylaxis. 1, 5 In our study, however, the percentage of patients receiving antibiotic treatment for wound 'infection' was lower in the gentamicin and amoxicillin group, which could be due to the broader spectrum of this regimen. The rate of C difficile 'infection' was also lower in the gentamicin and amoxicillin group, as was in a study where single-dose gentamicin was combined with single-dose cefuroxime. 6 In another report, the rate of C difficile infection reduced by 80% after cessation of cefuroxime. 10 Antibiotic exposure is associated with both C difficile diarrhoea and C difficile carriage. 11 The length of hospital stay increases when a patient develops C difficile infection. We therefore recommend antibiotic prophylaxis not associated with overgrowth of toxin-producing strains of C difficile.
The 180-day mortality was lower in the gentamicin and amoxicillin group, but the causes of death were not collected, and hence we cannot conclude that the difference in mortality was a result of the change of the antibiotic regimen.
A single preoperative dose avoids possible missed postoperative doses, in addition to reducing ward workload. Although the single-dose amoxicillin and gentamicin regimen is cost-effective, the prevalence of pathogens and their antibioticresistance patterns should also be taken into account when considering optimal prophylactic regimens in individual departments.
One of the limitations of this study was its retrospective nature. We had no data on other infections and organisms grown, or their susceptibility to the antibiotics administered. Further randomised controlled studies with larger numbers of patients are necessary to confirm these results.
acKnoWledgeMents
We thank Dr A Berrington and Mr P Dixon for their support.
disclosure
No conflicts of interest were declared by the authors.
